COEP
Coeptis Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
COEP Profile
Coeptis Therapeutics Holdings, Inc.
A biopharmaceutical company that developing innovative cell therapy platforms for cancer
Life Science Tools and Services
Invalid Date
12/17/2020
NASDAQ Stock Exchange
7
12-31
Common stock
105 Bradford Rd, Suite 420, Wexford, Pennsylvania, 15090
--
Coeptis Therapeutics Holdings, Inc., originally incorporated in Colorado in 1996 as Nelx Marketing Inc., later changed its name to Mind 2 Market, Inc. (1996) and then to Health Partnership, Inc. (2005), It was then renamed Naerodynamics, Inc. (2008). In January 2020, Coeptis moved to Delaware and changed its then corporate name to NDYN Merger Corp. In February 2020, NDYN Merger Corp. promulgated a holding company reorganization under Section 251 (g) of the DGCL and changed the company name to Vinings Holdings, Inc. Effective July 12, 2021, the company name will be changed to "Coeptis Therapeutics, Inc." Coeptis' current business model is designed around further developing its existing product portfolio. Coeptis is constantly exploring partnership opportunities with companies at different stages of development with new therapies or with technologies that improve the way they deliver medicines to patients. Coeptis seeks optimal strategic relationships that can include in-licensing agreements, out-of-licensing agreements, co-development arrangements, and other strategic partnerships in new and exciting therapeutic areas such as autoimmune diseases and oncology.